We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Formalizes Joint Plan for API Inspections With Partners
FDA Formalizes Joint Plan for API Inspections With Partners
April 2, 2012
The FDA and its EU and Australian counterparts have developed a blueprint for operating joint GMP inspections of active pharmaceutical ingredient (API) manufacturing facilities, the Australian Therapeutic Goods Administration (TGA) says.